There has been an observable trend, in the interventional radiology products market, demonstrating the shift in medical imaging and minimally invasive procedures. This includes but is not limited to a number of product types that are used in interventional radiology which is a discipline of medicine that uses images as guides for diagnosis or treatment. The Interventional Radiology Products Market has undergone significant transformations over the past few years, driven by technological change, increasing preference for non-invasive procedures and escalating demand for precision and speed in medical processes.
One major trend within the Interventional Radiology Products Market is the application of high-resolution imaging technologies during operations. For instance, with fluoroscopy, ultrasound machine as well as computed tomography (CT), intervention radiologists have been able to visualize and man oeuvre within human body more accurately compared to before. Besides making interventions safer and more effective than ever before this trend also makes possible minimally invasive methods for performing many other procedures.
In regard to interventional radiology applications, there has been a rise in minimal invasion techniques where incisions are smaller and there is less damage on surrounding tissues. It originates from patients fearing pain, allowing them to be treated faster with lower costs than could be incurred if it were otherwise. Such minimal invasion approaches depend heavily on interventional radiology devices like catheters or guidewires plus embolic agents among others products introduced into this sector by manufacturers. The market sees an increasing need for devices enabling an exact path through which drugs can be injected thus fueling growth of miniaturized surgeries.
Another important development within the Interventional Radiology Products Market is robotics and artificial intelligence (AI) being integrated into interventional practices. For example, robotics help doctors improve precision levels when using instruments thereby making it easier to handle complex procedures successfully. Moreover, AI algorithms on image analyzing facilitate diagnostics and treatment planning too. Consequently, these advanced systems are integrated into various products employed in interventional radiology and these are the most important steps in improving personalized and efficient patient care.
In addition, there is a shift towards ambulatory care and outpatient settings for the delivery of interventional radiology. Technology advancements together with low invasiveness seen in most interventions have made it possible to perform procedures on patients that do not require them to stay at the hospital for long periods. This aligns with wider healthcare objectives aimed at decreasing admissions, making services more convenient for patients and better utilization of resources. Outpatient oriented interventional radiology products are increasingly being embraced hence boosting market expansion.
Moreover, an emerging trend is the development of specialized interventional products tailored to specific medical conditions. In line with expanding range of intervention procedures, manufacturers now create specific devices for different maladies. A case in point is products meant for vascular interventions, oncology as well as neuro-interventions etc. As such, there is an increased availability of disease-specific interventional radiological products which enable medical practitioners choose instruments that suit their patients’ needs.
Innovation in Interventional Radiology Products Market comes from collaborations between industry players and healthcare institutions. This creates room for knowledge transfer, resource sharing as well as skill acquisition necessary in inventing new generation goods. There has been a great deal of synergy between manufacturers, researchers and clinicians leading to immediate commercialization of scientific breakthroughs related to new interventional radiology tools.
However, a few difficulties still persist in the market including standardizing training programs for medical professionals and dealing with radiation exposure arising from certain interventional procedures. Furthermore, making sure advanced interventional radiology products are affordable and accessible is an ongoing puzzle in the industry especially to developing nations.
The Interventional Radiology Products Market Size was valued at USD 25.3 Billion in 2022 and is projected to grow from USD 26.8 Billion in 2023 to USD 42.0 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.80% during the forecast period (2023 - 2032). The prevalence of chronic diseases like cancer and cardiovascular conditions is increasing worldwide, and consumers are adjusting their preferences to less intrusive methods are the key market drivers enhancing the market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The global population's increasing prevalence of chronic diseases including cancer and cardiovascular problems would be a key factor in boosting the expansion of the market for interventional radiology goods. The need for interventional radiology technologies including CT scans, MRIs, and ultrasounds will rise as customer preferences for minimally invasive procedures alter, which will accelerate market growth. The growing emphasis on the creation of smart/digital inhalers is another important element contributing to the market's growth. Additionally, rising healthcare costs and a growing need for painless drug administration are the main factors boosting market expansion. The increase in applications will also have a favorable effect on the market's growth rate. The market for interventional radiology products will increase at a slower rate due to rapid urbanization, changing lifestyles, and rising disposable income levels in both developing and developed nations. Increased elderly population and a good reimbursement environment would boost the market for interventional radiology products.
Additionally, the market expansion of the interventional radiology products will benefit from the increase in research and development efforts related to this field and the improvement of imaging technologies. The market for interventional radiology products will continue to increase in the future due to rising demand from emerging regions and the introduction of innovative products. Thus, driving the Interventional Radiology Products market revenue.
The Market segments of Interventional Radiology Products, based on Type includes stents, catheters, inferior vena cava (IVC) filters, embolization devices, thrombectomy systems, angioplasty balloons, biopsy needles, hemodynamic flow alteration devices, accessories, and other. In 2022, stents held the biggest market share for interventional radiology goods. The substantial proportion of this market can be attributable to the rising incidence of cancer and heart disorders as well as the rising frequency of angioplasty surgeries worldwide.
The Market segmentation of Interventional Radiology Products, based on Application, includes cardiology, oncology, gastroenterology, neurology, orthopedics, urology & nephrology, and others. The cardiology category dominated the market in 2022. Cardiology issues are growing more prevalent among adults and the elderly. The necessity for excellent treatment to treat this illness increases as patient’s age increases. Because of this, many nations are attempting to increase access to interventional radiology care.
Figure 1: Interventional Radiology Products Market, by Application, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The Interventional Radiology Products Market segmentation, based on end user, includes Hospitals, Clinics and Home Care Settings. The hospitals category dominated the market in 2022 due to increase prevalence of chronic diseases and presence of skilled professionals.
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America held a 45.8% market share and a USD 11.6 billion revenue lead in the market of interventional radiology products, and it will maintain this lead during the projection period. This is because the area has established healthcare infrastructure and a number of important key stakeholders. Further, the U.S. market of Interventional Radiology Products held the largest market share, and the Canada market of Interventional Radiology Products was the fastest growing market in the North America region.
Further, the major countries studied in the market report are The U.S., Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SHARE BY REGION 2022 (%)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The Europe Interventional Radiology Products market is anticipated to increase steadily. This is attributed to the region's growing cardiovascular disease patient population. Around 40% of adult and geriatric patients in Germany die from cardiovascular and chronic diseases. Further, the German market of Interventional Radiology Products held the largest market share, and the UK market of Interventional Radiology Products was the fastest growing market in the European region.
On the other hand, Asia-Pacific Interventional Radiology Products market is anticipated to experience the fastest growth rate over the projection period because of the region's growing senior population and increased prevalence of chronic diseases. The market is expanding primarily due to the rising geriatric population, expanding healthcare infrastructure, rising healthcare costs, and increasing acceptance of image-based therapeutic interventions. Moreover, China’s market of Interventional Radiology Products held the largest market share, and the Indian market of Interventional Radiology Products was the fastest growing market in the Asia-Pacific region.
Interventional Radiology Products Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the market of Interventional Radiology Products, grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Interventional Radiology Products industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global Interventional Radiology Products industry to benefit clients and increase the market sector. In recent years, the Interventional Radiology Products industry has offered some of the most significant advantages to medicine. Major players in the Interventional Radiology Products market, including Boston Scientific Corporation, Abbott, Cardinal Health, Cook, Stryker, B. Braun Melsungen AG, Terumo Corporation, General Electric, Koninklijke Philips N.V., Carestream Health, ESAOTE SPA, Hitachi, Ltd., Hologic, Inc., Shimadzu Corporation, Siemens Healthcare GmbH, CANON MEDICAL SYSTEMS CORPORATION, Samsung Medison Co., Ltd., Medtronic, Agfa-Gevaert Group, Teleflex Incorporated, Analogic Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Trivitron Healthcare, Toshiba International Corporation, and FUJIFILM Holdings Corporation, are attempting to increase market demand by investing in research and development operations.
Develops, produces, and sells printing systems and solutions under the name Konica Minolta Inc. Multifunctional peripherals (MFPs), equipment for graphic arts and production print systems, equipment for healthcare systems, and measurement tools for industrial and medical applications are all part of the company's product line. Additionally, it creates optical products, functional films, lighting source panels, and electronic materials for both industrial and commercial use. The business offers networking, services, and solutions for medical digitization. Additionally, Konica Minolta provides equipment for imaging, IoT, and visual applications. The business works through subsidiaries and affiliates in the Americas, Asia-Pacific, Europe and the Middle East, and Africa that are both consolidated and unconsolidated. The headquarters of Konica Minolta are in Tokyo, Japan's Chiyoda-ku. Konica Minolta Healthcare Americas introduced the Sonimage MX1 Platinum point-of-care ultrasound system in November 2022.
Fujifilm Holdings Corp. (Fujifilm) develops, produces, and sells imaging systems, material solutions, healthcare solutions, and document solutions. The business provides document solutions, including office supplies, printers for the workplace, allied production services, and international services. The company's main goods are color films, color paper and chemicals, photofinishing tools, electronic imaging and optical equipment, TV cameras, security lenses, healthcare items, graphic systems, flat panel display components, recording media, and industrial goods. Additionally, Fujifilm provides tools and materials for medicines, cosmetics, dietary supplements, cell culture medium and reagents, and medical systems. Both individual consumers and commercial entities are served by the corporation. The corporation operates in the Asia-Pacific, Europe, and the Americas. The headquarters of Fujifilm are in Minato-Ku, Tokyo, Japan. The Scenaria View Focus Edition Computed Tomography (CT) system, a high-end scanner with an advanced Cardiac Motion Correction function called Cardio StillShot, will go on sale in the United States in November 2022, according to a press release from Fujifilm Healthcare Americas Corporation.
Key Companies in the Interventional Radiology Products market include
Interventional Radiology Products Industry Developments
October 2022 The new Omni Legend all-digital PET/CT platform from GE Healthcare was released to improve operational effectiveness.
February 2021Â The radial artery access portfolio was purchased by Medtronic (Ireland) from RIST Neurovascular, Inc. The company's product line in the market for interventional radiology goods was widened by this acquisition, which also improved its capacity to assist patients who require interventional neurovascular therapy.
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)